Accordant Advisory Group’s Uranium Royalty Corp UROY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.48M Buy
2,690,476
+180,288
+7% +$632K 5.04% 6
2026
Q1
$9.16M Buy
2,510,188
+39,699
+2% +$162K 5.68% 6
2025
Q4
$8.75M Buy
2,470,489
+19,882
+0.8% +$77.8K 6.04% 6
2025
Q3
$10.5M Buy
2,450,607
+8,905
+0.4% +$26.9K 7.17% 4
2025
Q2
$6.1M Buy
2,441,702
+107,216
+5% +$217K 4.55% 6
2025
Q1
$4.11M Buy
2,334,486
+2,049,409
+719% +$4.39M 4.02% 8
2024
Q4
$624K Buy
+285,077
New +$733K 0.6% 27

Other funds holding UROY

Accordant Advisory Group's UROY Position: Q2 2026 in Review

Accordant Advisory Group increased its Uranium Royalty Corp (UROY) stake by 7.2% in Q2 2026, buying an estimated $632K and bringing the position to 2,690,476 shares worth $7.48M. The position accounts for 5.04% of the portfolio, ranked #6.

Accordant Advisory Group first reported a position in UROY in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.5M in Q3 2025. 113 funds tracked by Wall St. Rank hold UROY as of Q2 2026.

  • Accordant Advisory Group held 2,690,476 shares of Uranium Royalty Corp worth $7.48M as of Q2 2026.
  • Accordant Advisory Group bought 180,288 Uranium Royalty Corp shares in Q2 2026, an estimated $632K.
  • Uranium Royalty Corp made up 5.04% of Accordant Advisory Group's portfolio in Q2 2026, its #6 holding.
  • Accordant Advisory Group first reported a position in Uranium Royalty Corp in Q4 2024 and has held it in 7 quarters since.
  • Accordant Advisory Group's Uranium Royalty Corp position peaked at $10.5M in Q3 2025.
  • 113 funds tracked by Wall St. Rank held Uranium Royalty Corp as of Q2 2026.

Based on Accordant Advisory Group's 13F filing for Q2 2026, filed 27 Jul 2026.